Article info
PDFImage of the moment
Multiple system atrophy mimicked by multi-organ pathology
- Correspondence to Dr Jane Alty, Department of Neurology, Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK; jane.alty{at}nhs.net
Citation
Multiple system atrophy mimicked by multi-organ pathology
Publication history
- Received February 12, 2019
- Revised February 24, 2019
- Accepted March 4, 2019
- First published April 11, 2019.
Online issue publication
June 23, 2020
Article Versions
- Previous version (23 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland
- Affective symptoms in multiple system atrophy and Parkinson’s disease: response to levodopa therapy
- Multiple system atrophy
- Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy
- Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests
- What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?
- Improving the diagnostic accuracy in parkinsonism: a three-pronged approach
- Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study
- Clinical usefulness of magnetic resonance imaging in multiple system atrophy
- MRI signs of multiple system atrophy preceding the clinical diagnosis: the case for an imaging-supported probable MSA diagnostic category